Long-Term (Three-Year) Safety and Efficacy of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents (from the SPIRIT III Trial)-Reference-Cited by-同舟云学术

Long-Term (Three-Year) Safety and Efficacy of Everolimus-Eluting Stents Compared to Paclitaxel-Eluting Stents (from the SPIRIT III Trial)

Published:2011-03 Issue:6 Volume:107 Page:833-840
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Applegate Robert J.,Yaqub Manejeh,Hermiller James B.,Sood Poornima,Yu Shui,Doostzadeh Julie,Williams Jerome E.,Farhat Naim,Caputo Ronald,Lansky Alexandra J.,Cutlip Donald E.,Sudhir Krishnankutty,Stone Gregg W.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. 3-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions

2. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: A randomized trial;Stone;JAMA,2008

3. Randomized Comparison of Everolimus-Eluting and Paclitaxel-Eluting Stents

4. Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trial;Claessen;Circ Cardiovasc Interv,2009

5. Clinical end points in coronary stent trials: A case for standardized definitions;Cutlip;Circulation,2007

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Cardiovascular Frontiers: A Dive Into Cutting-Edge Innovations in Coronary Stent Technology;Cardiology in Review;2024-05-06

2. In‐Stent Restenosis in the New Generation DES Era;Interventional Cardiology;2022-05-06

3. Pathological findings after third- and second-generation everolimus-eluting stent implantations in coronary arteries from autopsy cases and an atherosclerotic porcine model;Scientific Reports;2021-03-18

4. Second generation drug-eluting stents: a focus on safety and efficacy of current devices;Expert Review of Cardiovascular Therapy;2021-02-01

5. First-generation versus second-generation drug-eluting stents in patients with chronic kidney disease: a systematic review and meta-analysis;Postgraduate Medicine;2018-12-03